Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE

Background: Hyperfunctional platelets play important roles in thromboembolism in patients with β-thalassaemia/ haemoglobin E (β-thal/HbE). Our previous study revealed ex vivo inhibitory effects of deferiprone on normal platelets. Herein, we aimed to investigate the in vivo effects on platelets in pa...

Повний опис

Бібліографічні деталі
Автори: Ngan Thi Tran, Pranee Sutcharitchan, Jindaporn Janprasit, Ponlapat Rojnuckarin, Noppawan Phumala Morales, Rataya Luechapudiporn
Формат: Стаття
Мова:English
Опубліковано: BioExcel Publishing Ltd 2022-12-01
Серія:Drugs in Context
Предмети:
arachidonic acid
deferiprone
iron overload
platelet aggregation
p-selectin
thalassaemia
Онлайн доступ:https://www.drugsincontext.com/deferiprone-an-iron-chelator-alleviates-plateletbrhyperactivity-in-patients-with-%ce%b2-thalassaemia-hb-e/

Інтернет

https://www.drugsincontext.com/deferiprone-an-iron-chelator-alleviates-plateletbrhyperactivity-in-patients-with-%ce%b2-thalassaemia-hb-e/

Схожі ресурси